Evaluation of changes in tumor volume following upfront chemotherapy for locally advanced Non Small Cell Lung Cancer (NSCLC)
Sager Omer, Ferrat Dinçoğlan, Selçuk Demiral, Beyzadeoglu Murat
Abstract
Objective: In the setting of upfront chemotherapy, some degree of reduction in primary tumor volume may occur. This may be of critical importance in the setting of locally advanced Non Small Cell Lung Cancer (NSCLC) when upfront defi nitive irradiation is not feasible due to critical organ dose constraints. Selected patients with tumor volume reduction after upfront systemic therapy may be considered for curative radiation therapy (RT). To address this issue, we evaluated changes in tumor volume following upfront chemotherapy for NSCLC in this original article.
Topics & Concepts
MedicineChemotherapyLung cancerOncologyInternal medicineRadiation therapySurgical oncologyLung Cancer Diagnosis and TreatmentAdvanced Radiotherapy TechniquesBrain Metastases and Treatment